Is Semax appropriate alongside SSRIs or other psychiatric medications?

Semax's pharmacology is generally additive rather than competitive with most psychiatric medications, but the combined modulation of monoamine systems warrants supervision. Users on SSRIs, SNRIs, lithium, or atypical antipsychotics should consult their prescriber before adding Semax to the regimen.

How long until I notice cognitive effects?

Mood and gut-related symptoms often shift within 5–14 days. Cognitive recovery and inflammation-related changes accumulate across 4–8 weeks. Stimulant-like 'feel it today' effects are not the typical Semax profile; the compound is restorative rather than acutely activating.

Best route for cognitive applications — injection or intranasal?

For most Semax cognitive use cases, the route that delivers the compound closest to its target site of action is preferred. Intranasal delivery via the olfactory pathway is the standard for direct CNS access where available.

Is Semax appropriate alongside SSRIs or other psychiatric medications?

Semax's pharmacology is generally additive rather than competitive with most psychiatric medications, but the combined modulation of monoamine systems warrants supervision. Users on SSRIs, SNRIs, lithium, or atypical antipsychotics should consult their prescriber before adding Semax to the regimen.

How long until I notice cognitive effects?

Mood and gut-related symptoms often shift within 5–14 days. Cognitive recovery and inflammation-related changes accumulate across 4–8 weeks. Stimulant-like 'feel it today' effects are not the typical Semax profile; the compound is restorative rather than acutely activating.

Best route for cognitive applications — injection or intranasal?

For most Semax cognitive use cases, the route that delivers the compound closest to its target site of action is preferred. Intranasal delivery via the olfactory pathway is the standard for direct CNS access where available.

Is Semax appropriate alongside SSRIs or other psychiatric medications?

Semax's pharmacology is generally additive rather than competitive with most psychiatric medications, but the combined modulation of monoamine systems warrants supervision. Users on SSRIs, SNRIs, lithium, or atypical antipsychotics should consult their prescriber before adding Semax to the regimen.

How long until I notice cognitive effects?

Mood and gut-related symptoms often shift within 5–14 days. Cognitive recovery and inflammation-related changes accumulate across 4–8 weeks. Stimulant-like 'feel it today' effects are not the typical Semax profile; the compound is restorative rather than acutely activating.

Best route for cognitive applications — injection or intranasal?

For most Semax cognitive use cases, the route that delivers the compound closest to its target site of action is preferred. Intranasal delivery via the olfactory pathway is the standard for direct CNS access where available.

How long until I notice cognitive effects?

Mood and gut-related symptoms often shift within 5–14 days. Cognitive recovery and inflammation-related changes accumulate across 4–8 weeks. Stimulant-like 'feel it today' effects are not the typical Semax profile; the compound is restorative rather than acutely activating.

Is Semax appropriate alongside SSRIs or other psychiatric medications?

Semax's pharmacology is generally additive rather than competitive with most psychiatric medications, but the combined modulation of monoamine systems warrants supervision. Users on SSRIs, SNRIs, lithium, or atypical antipsychotics should consult their prescriber before adding Semax to the regimen.

How should Semax be stored and reconstituted?

Lyophilised Semax stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

Is Semax a stimulant or a restorative?

Semax is best characterised as a modulator with both restorative and modest activating components. The cognitive value emerges through reduction of chronic neuroinflammation, support for monoamine and neurotrophic systems, and stabilisation of the upstream physiology on which attention and memory depend. Stimulant-like acute effects are not the typical profile.

Is Semax safe during pregnancy or breastfeeding?

Semax, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

What route should I use for Semax?

Semax is delivered by intranasal. The intranasal route is preferred for compounds targeting the central nervous system because it bypasses the BBB via the olfactory pathway. The choice depends on target system and convenience.

Home/ Compounds/ Semax

Semax

Neuroprotection

Cognitive performance and neurological recovery applications of Semax centre on its relationship to cerebral perfusion, BDNF and NGF signalling, and the gut-brain inflammatory axis. A Russian-developed analogue of ACTH(4-10) extended with a Pro-Gly-Pro tail for proteolytic stability — a clinically used nootropic and stroke recovery agent. A 7-residue acth-derived nootropic heptapeptide, Semax is investigated in nootropic, post-injury, and chronic-neuroinflammation contexts; the cognitive endpoints accumulate across 4-8 weeks rather than appearing acutely.

Cognitive / Neurological Applications

Post-TBI RecoveryDopamine ModulationSleep ArchitectureGut-Brain AxisMood Stabilisation

Key Takeaways

Cognitive lens: Semax acts as a modulator with both restorative and modest activating components for cognitive endpoints.
CNS access pattern: BBB transport plus vagal-afferent gut-brain signalling and cerebral vascular effects.
Mechanism: Elevates BDNF and NGF in hippocampus and cortex.
Neuro dose: 300-2000 mcg per dose (varies) 2-4x daily for 10-14 day courses via intranasal; cognitive effects accumulate across 4-8 weeks.
Cognitive stack partners: Selank, Semax + Selank Blend, DSIP.

Cognitive / Neurological Mechanism

Three pathways shape Semax's cognitive profile: Elevates BDNF and NGF in hippocampus and cortex. Modulates dopamine and serotonin transporter expression. Inhibits enkephalinase, indirectly extending endogenous enkephalin action. Approved in Russia for stroke rehabilitation and cognitive disorders. Each subsection below covers one - CNS access mechanisms, neurotrophic and monoamine effects, and the inflammation-and-recovery layer that often produces the most subjectively reported cognitive shifts.

Inflammation and neurological recovery

One of the most replicated effects across compounds in Semax's class (ACTH-derived nootropic heptapeptide) is reduction of inflammatory cytokines (TNF-α, IL-1β, IL-6) in tissues including the central nervous system. For users whose cognitive complaints track with chronic low-grade neuroinflammation — long-COVID, post-viral cognitive fog, post-concussion lingering symptoms, chronic stress — this anti-inflammatory layer is often the most operationally relevant mechanism. Semax's contribution operates on the same axis at 300-2000 mcg per dose (varies) per dose.

Central nervous system access

Semax reaches the central nervous system through one or more of three documented routes: direct blood-brain barrier transport, vagal-afferent signalling via the gut-brain axis, and direct action on cerebral vasculature in regions where the barrier is locally compromised. The compound's intranasal route(s) and CNS effect hours; plasma minutes half-life set the timeline for CNS exposure. Elevates BDNF and NGF in hippocampus and cortex. The CNS-relevant phenotype that emerges from this mechanism is the substrate of the cognitive effects described below.

Cerebral perfusion and the structural cognitive substrate

Cognitive function depends on adequate cerebral perfusion, intact endothelial signalling, and a low chronic-inflammatory tone in the brain parenchyma. Semax, with its Elevates BDNF and NGF in hippocampus and cortex Modulates dopamine and serotonin transporter expression. Inhibits enkephalinase, indirectly extending endogenous enkephalin action. Approved in Russia for stroke rehabilitation and cognitive disorders. mechanism, contributes to this substrate rather than producing acute stimulant-like activation. Across the cognitive applications outlined below, what users describe is restoration of baseline rather than amplification above it. The CNS effect hours; plasma minutes pharmacokinetic profile supports this restorative rather than stimulant phenotype.

Cognitive / Neurological Applications

BDNF Support

For bdnf support, Semax is most-relevant in users whose cognitive complaints track with chronic neuroinflammation or post-injury recovery. Effect size is modest but consistent across well-tolerated dose ranges, with typical response window of 4–8 weeks.

Anxiety

Anxiety is one of the more-reported subjective benefits of Semax across cognitive-focused user cohorts. The mechanism is plausible given the compound's neurotrophic and anti-inflammatory profile; the effect size depends substantially on baseline status.

Dopamine Modulation

Where Semax is used for dopamine modulation, the dosing window is typically 4–8 weeks with re-evaluation at the end of cycle. Stacking with selank or semax is common in this use case; pure-isolated dosing is also viable for first-cycle users.

Neuroprotection

For neuroprotection, Semax is most-relevant in users whose cognitive complaints track with chronic neuroinflammation or post-injury recovery. Effect size is modest but consistent across well-tolerated dose ranges, with typical response window of 4–8 weeks.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	Intranasal	300-2000 mcg per dose (varies)	8–12 weeks on / 4 weeks off
Conservative starter	Intranasal	180-2000 mcg per dose (varies)	4–6 weeks initial cycle
Neuroprotection focus	Intranasal	300-2000 mcg per dose (varies)	2-4x daily for 10-14 day courses
Maintenance phase	Intranasal	210-2000 mcg per dose (varies)	Ongoing with periodic pauses

Dose timing for Semax is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

Semax stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from the cognitive neuroscience community.

Semax + Selank: Modulates GABA-A receptor systems indirectly. Pairs naturally with Semax's mechanism in cognitive / neurological protocols.
Semax + Semax + Selank Blend: Semax raises BDNF and modulates dopamine systems; Selank stabilises GABAergic and serotonergic tone. Pairs naturally with Semax's mechanism in cognitive / neurological protocols.
Semax + DSIP: Mechanism remains incompletely characterised. Pairs naturally with Semax's mechanism in cognitive / neurological protocols.
Semax + LL-37: Amphipathic α-helical peptide cleaved from hCAP-18 by proteinase 3. Pairs naturally with Semax's mechanism in cognitive / neurological protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved (approved in Russia) Research: Multi-decade Russian clinical use

Excellent tolerability. Mild nasal irritation possible. No dependence.

Lens-specific safety considerations for cognitive / neurological use of Semax: Excellent tolerability. Mild nasal irritation possible. No dependence. Additional cognitive / neurological monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Semax — neuroprotective effects

PMID 8941050

Supporting

Semax in ischemic stroke recovery

PMID 21643748

Semax vs Related Peptides

Compound	Profile	Onset	Best For
Semax	ACTH-derived nootropic heptapeptide	CNS effect hours; plasma minutes	Neuroprotection
Selank	Tuftsin-derived heptapeptide anxiolytic	CNS effect lasts hours; plasma short	A Russian-developed heptapeptide derived from tuftsin — anxiolytic without sedation, supported by clinical trial data in generalised anxiety disorder
DSIP	Neuropeptide (sleep)	~7 min plasma; CNS effects longer	A short neuropeptide isolated from sleeping rabbits in 1977, of interest for its modulation of delta-wave sleep and stress resilience
Pinealon	Khavinson tripeptide (pineal-derived)	Short plasma; durable tissue effects	A Khavinson pineal-derived tripeptide of glutamate-aspartate-arginine, studied for neuroprotection and cognitive function in aged and ischemic models

Frequently Asked Questions

Does Semax cross the blood-brain barrier?

Direct BBB passage is variable across peptide compounds and is rarely the dominant mechanism. Semax produces CNS effects through some combination of: direct BBB transport (at low efficiency for most peptides), vagal-afferent gut-brain axis signalling, and effects on cerebral vasculature where the barrier is locally compromised. The CNS effects observed in research consistently appear at peripheral doses, supporting the indirect-access framework.

Cognitive side effects to watch for?

Reported issues are uncommon in animal and limited human data but include mild sedation, vivid dreams, transient mood lability in the first week, and infrequent headache. There are no large-scale human safety trials. Discontinue if mood symptoms are concerning and re-evaluate.

Is Semax a true nootropic?

Not in the caffeine-or-modafinil sense. Semax does not acutely sharpen attention or working memory in healthy users. Its cognitive value is restorative — supporting recovery from neurological injury, reducing chronic neuroinflammation, and stabilising the upstream systems that cognitive function depends on.

Can Semax be stacked with other nootropics?

Yes, and it is commonly paired. The cleanest pairings are with compounds on complementary pathways — anxiolytic (selank), neurotrophic (semax), sleep-architecture (DSIP), or anti-inflammatory (LL-37) — rather than with other compounds engaging the same pathway.

What is Semax?

Semax (also known as Pro-Gly-Pro-ACTH(4-10) / MEHFPGP) is a 7-residue acth-derived nootropic heptapeptide with a molecular weight of 813 Da and a plasma half-life of CNS effect hours; plasma minutes. Elevates BDNF and NGF in hippocampus and cortex. Modulates dopamine and serotonin transporter expression. Inhibits enkephalinase, indirectly extending endogenous enkephalin action. Approved in Russia for stroke rehabilitation and cognitive disorders. The compound is studied primarily in the cognitive / neurological domain for the applications outlined above.

What is the standard dosing protocol for Semax?

Conventional Semax dosing is 300-2000 mcg per dose (varies) 2-4x daily for 10-14 day courses via intranasal. For cognitive and neurological use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

Clinical Protocol

Start a Semax Protocol

Alukard provides physician-supervised cognitive protocols with GMP-certified Semax and GMP-certified compounds and comprehensive neurological assessments.

Get Protocol

Quick Facts

Molecular weight: 813 Da
Sequence length: 7 aa
Half-life: CNS effect hours; plasma minutes
WADA: Not on prohibited list
FDA: Unapproved (approved in Russia)
Research: Multi-decade Russian clinical use

Stack Partners

Selank

Semax + Selank Blend

DSIP

LL-37

Research Note

All cognitive / neurological applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Semax unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised cognitive protocols

Start Your Cognitive / Neurological Protocol for Semax

Alukard provides physician-supervised cognitive protocols with GMP-certified compounds and comprehensive neurological assessments.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised